Loading...
Novel Therapeutic Agents Against Cancer Stem Cells of Chronic Myeloid Leukemia
Chronic myeloid leukemia (CML) is induced by the BCR-ABL oncogene, a product of Philadelphia (Ph) chromosome. The BCR-ABL kinase inhibitor imatinib is a standard treatment for Ph(+) leukemia, and has been shown to induce a complete hematologic and cytogenetic response in most chronic phrase CML pati...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3136127/ https://ncbi.nlm.nih.gov/pubmed/20184539 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|